Collectively, these observations suggest that while cancer cells respond similarly, in terms of cell viability in vitro, to the loss of CDK9 and key factors controlling transcription, this is not the case for the majority of tCDKs, including CDK7. This evidence concerns the gene CDK7 and cancer.